Sectors

Intermountain Ventures, already among the medical chatbot developer's customers, participated in a $13.6m round that took its total funding past $20m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The ophthalmologic drug developer has gone public three years after being founded by WuXi AppTec-backed 6 Dimensions Capital.

Pfizer Ventures, billed as an existing investor, contributed to the $72.5m close of the antibody-drug conjugate developer's latest round.

Tiger Global led a series D round that doubled Slack-backed workforce engagement software provider Lattice's valuation to $400m.

The ultrasound system developer's Edwards Lifesciences-backed series B round will fund product development and commercial growth.

The network management technology provider, which counts Cisco, Dell, Salesforce, Deutsche Telekom and Telstra as investors, has now raised $125m in total.

Gilead Sciences returned for a $46.7m round that will support further development of its biosensor-based diagnostics device.

University of Toronto and McMaster University-founded glioblastoma Car T-cell therapy developer Empirca Therapeutics has been acquired by Century Therapeutics.

MediaMath affiliate MathCapital took part in a round that increased the customer data provider's overall funding to more than $62m.

Telstra Ventures was among the investors in the equity portion of cloud data storage provider Nasuni's latest round, lifting its total equity funding to $169m.